by Technode Global Staff for Technode Global

“Mirxes Holding Company Limited, a Singapore-headquartered biotech firm, announced Tuesday that it has filed listing application with The Stock Exchange of Hong Kong Limited after securing $50 million Series D funding.

Mirxes said in a statement this Series D funding is anchored by existing and new investors, including Beijing Fupu which the Management Committee of Zhejiang Anji Economic Development Zone indirectly owned a majority stake.

EDB Investments Pte Ltd, wholly owned by the Singapore Economic Development Board, Agency for Science, Technology and Research, Singapore’s lead public sector research and development (R&D) agency for scientific discovery and technological innovation, Mitsui & Co., Ltd., a company which is listed in various stock exchanges in Japan, and NHH Venture Fund, also participated in the round…”

Continue reading at the original source, linked here.